Musculoskeletal Transplant Foundation Inc
Musculoskeletal Transplant Foundation: Leading Tissue Bank with Strong Program Spending
EIN: 222803458 · Edison, NJ · NTEE: E60 · Updated: 2026-04-04
| Metric | Value |
|---|---|
| Total Revenue | $511.9M |
| Total Expenses | $488.7M |
| Program Spending | 85% |
| CEO/Top Officer Pay | $1,050,000, |
| Net Assets | $110.2M |
| Transparency Score | 85/100 |
Is Musculoskeletal Transplant Foundation Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Musculoskeletal Transplant Foundation Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Musculoskeletal Transplant Foundation Inc
Musculoskeletal Transplant Foundation Inc (EIN: 222803458) is a nonprofit organization based in Edison, NJ, classified under NTEE code E60. The organization reported total revenue of $511.9M and total assets of $323.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Musculoskeletal Transplant Foundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Musculoskeletal Transplant Foundation Inc is a major nonprofit that has been operating for 30 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 1.8%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $493.5M |
| Total Expenses | $488.7M |
| Surplus / Deficit | +$4.8M |
| Total Assets | $323.2M |
| Total Liabilities | $213.0M |
| Net Assets | $110.2M |
| Operating Margin | 1.0% |
| Debt-to-Asset Ratio | 65.9% |
| Months of Reserves | 7.9 months |
Financial Health Grade: A
In 2023, Musculoskeletal Transplant Foundation Inc reported a surplus of $4.8M with revenue exceeding expenses, holds 7.9 months of operating reserves (strong position), has a debt-to-asset ratio of 65.9% (high leverage).
Financial Trends
Over 13 years of filings (2011–2023), Musculoskeletal Transplant Foundation Inc's revenue has grown at a compound annual growth rate (CAGR) of 1.8%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +0.5% | +4.1% | -0.3% |
| 2022 | +6.1% | +5.2% | +20.8% |
| 2021 | +12.4% | +7.3% | +1.0% |
| 2020 | -10.7% | -8.2% | -1.4% |
| 2019 | +6.9% | +4.2% | +6.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1996 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Musculoskeletal Transplant Foundation Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Musculoskeletal Transplant Foundation Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $4.8M, with revenue exceeding expenses.
- Debt-to-asset ratio: 65.9%.
Executive Compensation Analysis
In 2022, the CEO's total compensation was $1,050,000, which appears reasonable given the organization's scale and revenue of over $490 million, aligning with industry standards for large non-profits.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Musculoskeletal Transplant Foundation Inc:
- Consistently high program spending, with 85% of expenses dedicated to programs in 2022.
- Significant revenue generation, exceeding $490 million in 2022, indicating strong operational capacity.
- Maintains substantial assets ($324 million in 2022) to support its mission and operations.
- A leader in the tissue banking industry, contributing significantly to medical advancements and patient care.
- Demonstrates consistent financial health and growth over several years.
Frequently Asked Questions about Musculoskeletal Transplant Foundation Inc
Is Musculoskeletal Transplant Foundation Inc a legitimate charity?
Musculoskeletal Transplant Foundation Inc (EIN: 222803458) is a registered tax-exempt nonprofit based in New Jersey. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $511.9M. No red flags identified. 5 strengths noted. Financial health grade: A.
How does Musculoskeletal Transplant Foundation Inc spend its money?
Musculoskeletal Transplant Foundation Inc directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Musculoskeletal Transplant Foundation Inc tax-deductible?
Musculoskeletal Transplant Foundation Inc is registered as a tax-exempt nonprofit (EIN: 222803458). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Musculoskeletal Transplant Foundation Inc CEO make?
Musculoskeletal Transplant Foundation Inc's highest-compensated officer earns $1,050,000, annually. The organization reported $511.9M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Musculoskeletal Transplant Foundation Inc's spending goes to programs?
Musculoskeletal Transplant Foundation Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Musculoskeletal Transplant Foundation Inc compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Musculoskeletal Transplant Foundation Inc is above average for NTEE category E60 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Musculoskeletal Transplant Foundation Inc located?
Musculoskeletal Transplant Foundation Inc is headquartered in Edison, New Jersey and files with the IRS under EIN 222803458. It is classified under NTEE code E60.
How many years of IRS 990 filings does Musculoskeletal Transplant Foundation Inc have?
Musculoskeletal Transplant Foundation Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $511.9M in total revenue.
What does Musculoskeletal Transplant Foundation Inc do?
Musculoskeletal Transplant Foundation Inc is a nonprofit organization in the Health Care sector, located in Edison, New Jersey. It is classified under NTEE code E60.
How much revenue does Musculoskeletal Transplant Foundation Inc have?
Musculoskeletal Transplant Foundation Inc reported total revenue of $511,923,653. Based on 13 IRS 990 filings on record.
What are Musculoskeletal Transplant Foundation Inc's total assets?
Musculoskeletal Transplant Foundation Inc holds total assets of $323,446,458 as reported in IRS 990 filings.
Where is Musculoskeletal Transplant Foundation Inc located?
Musculoskeletal Transplant Foundation Inc is based in Edison, New Jersey.
What is Musculoskeletal Transplant Foundation Inc's EIN?
Musculoskeletal Transplant Foundation Inc's Employer Identification Number (EIN) is 222803458. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is Musculoskeletal Transplant Foundation Inc?
Musculoskeletal Transplant Foundation Inc is classified under NTEE code E60 (Health Care).
Is Musculoskeletal Transplant Foundation Inc a registered 501(c)(3)?
Yes, Musculoskeletal Transplant Foundation Inc is recognized as a tax-exempt organization by the IRS. EIN: 222803458.
Does Musculoskeletal Transplant Foundation Inc file IRS Form 990?
Yes, Musculoskeletal Transplant Foundation Inc has 13 IRS Form 990 filings on record. The most recent covers tax period 202312.
What was Musculoskeletal Transplant Foundation Inc's revenue in 2023?
In the 202312 filing period, Musculoskeletal Transplant Foundation Inc reported total revenue of $493,471,813, total expenses of $488,670,194, and net assets of $323,206,971.
Is Musculoskeletal Transplant Foundation Inc's revenue growing or declining?
Musculoskeletal Transplant Foundation Inc's revenue is relatively stable. Revenue went from $490,881,944 (202212) to $493,471,813 (202312), a +0.5% change. Based on 13 filings on record.
What is Musculoskeletal Transplant Foundation Inc's most recent 990 filing?
The most recent IRS Form 990 filing for Musculoskeletal Transplant Foundation Inc covers tax period 202312. It shows revenue of $493,471,813, expenses of $488,670,194, total assets of $323,206,971, and liabilities of $212,992,800.
How much does Musculoskeletal Transplant Foundation Inc spend on programs vs administration?
Based on IRS 990 analysis, Musculoskeletal Transplant Foundation Inc allocates approximately 85% of expenses to program services, 10% to administrative costs, and 5% to fundraising. This indicates strong program focus.
Is Musculoskeletal Transplant Foundation Inc a trustworthy charity?
Based on AI analysis of IRS 990 data, Musculoskeletal Transplant Foundation Inc appears trustworthy. Mission Score: 85/100 (Excellent). No red flags identified. 5 strengths noted.
What are Musculoskeletal Transplant Foundation Inc's strengths?
Positive indicators for Musculoskeletal Transplant Foundation Inc include: Consistently high program spending, with 85% of expenses dedicated to programs in 2022.. Significant revenue generation, exceeding $490 million in 2022, indicating strong operational capacity.. Maintains substantial assets ($324 million in 2022) to support its mission and operations.. A leader in the tissue banking industry, contributing significantly to medical advancements and patient care.. Demonstrates consistent financial health and growth over several years.. These findings are derived from AI analysis of the organization's financial filings.
How does Musculoskeletal Transplant Foundation Inc compensate executives?
In 2022, the CEO's total compensation was $1,050,000, which appears reasonable given the organization's scale and revenue of over $490 million, aligning with industry standards for large non-profits. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
How transparent is Musculoskeletal Transplant Foundation Inc?
- MTF provides detailed financial statements and 990 forms on its website, including audited financials. - The organization clearly outlines its mission and programs, offering insight into its tissue recovery, processing, and distribution activities. - Transparency regarding executive compensation is available in their Form 990 filings. Transparency assessment is based on the availability and consistency of IRS 990 filing data, spending disclosure, and governance indicators.
How does MTF's unique position as a tissue bank impact its financial model compared to other types of non-profits?
MTF's role as a tissue bank involves significant operational costs related to tissue recovery, processing, storage, and distribution, which are reflected in its high program expenses. This model differs from many service-based non-profits as it requires substantial infrastructure and regulatory compliance, influencing its revenue generation through service fees and grants rather than solely donations.
What strategies does MTF employ to maintain its strong financial position and asset base?
MTF maintains its strong financial position through a combination of consistent revenue from its tissue services, effective cost management, and strategic investment in its operational infrastructure. The organization's substantial asset base, including over $324 million in 2022, suggests a focus on long-term sustainability and capacity building to support its extensive operations and research initiatives.
Filing History
IRS 990 filing history for Musculoskeletal Transplant Foundation Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Musculoskeletal Transplant Foundation Inc's revenue has grown by 24.4%, moving from $396.7M to $493.5M. Total assets increased by 51.2% over the same period, from $213.8M to $323.2M. Total functional expenses rose by 23.9%, from $394.5M to $488.7M. In its most recent filing year (2023), Musculoskeletal Transplant Foundation Inc reported a surplus of $4.8M, with revenue exceeding expenses. The organization holds $213.0M in liabilities against $323.2M in assets (debt-to-asset ratio: 65.9%), resulting in net assets of $110.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $493.5M | $488.7M | $323.2M | $213.0M | — | View 990 |
| 2022 | $490.9M | $469.3M | $324.1M | $219.9M | — | View 990 |
| 2021 | $462.6M | $446.0M | $268.3M | $185.3M | — | View 990 |
| 2020 | $411.6M | $415.7M | $265.7M | $199.5M | — | View 990 |
| 2019 | $460.8M | $453.1M | $269.4M | $206.4M | — | View 990 |
| 2018 | $431.0M | $434.8M | $253.9M | $199.7M | — | View 990 |
| 2017 | $422.8M | $422.9M | $254.5M | $203.4M | — | View 990 |
| 2016 | $423.0M | $436.9M | $254.9M | $203.1M | — | View 990 |
| 2015 | $427.5M | $443.1M | $259.2M | $187.4M | — | View 990 |
| 2014 | $432.8M | $433.3M | $268.5M | $175.5M | — | View 990 |
| 2013 | $430.1M | $435.2M | $262.3M | $174.8M | — | View 990 |
| 2012 | $404.9M | $421.4M | $249.2M | $142.5M | — | View 990 |
| 2011 | $396.7M | $394.5M | $213.8M | $94.1M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $493.5M, expenses of $488.7M, and assets of $323.2M (revenue +0.5% year-over-year).
- 2022: Revenue of $490.9M, expenses of $469.3M, and assets of $324.1M (revenue +6.1% year-over-year).
- 2021: Revenue of $462.6M, expenses of $446.0M, and assets of $268.3M (revenue +12.4% year-over-year).
- 2020: Revenue of $411.6M, expenses of $415.7M, and assets of $265.7M (revenue -10.7% year-over-year).
- 2019: Revenue of $460.8M, expenses of $453.1M, and assets of $269.4M (revenue +6.9% year-over-year).
- 2018: Revenue of $431.0M, expenses of $434.8M, and assets of $253.9M (revenue +1.9% year-over-year).
- 2017: Revenue of $422.8M, expenses of $422.9M, and assets of $254.5M (revenue +-0.0% year-over-year).
- 2016: Revenue of $423.0M, expenses of $436.9M, and assets of $254.9M (revenue -1.1% year-over-year).
- 2015: Revenue of $427.5M, expenses of $443.1M, and assets of $259.2M (revenue -1.2% year-over-year).
- 2014: Revenue of $432.8M, expenses of $433.3M, and assets of $268.5M (revenue +0.6% year-over-year).
- 2013: Revenue of $430.1M, expenses of $435.2M, and assets of $262.3M (revenue +6.2% year-over-year).
- 2012: Revenue of $404.9M, expenses of $421.4M, and assets of $249.2M (revenue +2.1% year-over-year).
- 2011: Revenue of $396.7M, expenses of $394.5M, and assets of $213.8M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Musculoskeletal Transplant Foundation Inc:
Data Sources and Methodology
This transparency report for Musculoskeletal Transplant Foundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.